Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,659,840
  • Shares Outstanding, K 1,245,853
  • Annual Sales, $ 27,116 M
  • Annual Income, $ 5,665 M
  • 60-Month Beta 0.22
  • Price/Sales 3.02
  • Price/Cash Flow 7.34
  • Price/Book 4.68
Trade GILD with:

Options Overview Details

View History
  • Implied Volatility 22.52% ( +0.05%)
  • Historical Volatility 18.87%
  • IV Percentile 60%
  • IV Rank 45.58%
  • IV High 29.79% on 10/27/23
  • IV Low 16.44% on 12/05/23
  • Put/Call Vol Ratio 0.67
  • Today's Volume 10,657
  • Volume Avg (30-Day) 28,736
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 282,711
  • Open Int (30-Day) 298,736

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.59
  • Number of Estimates 11
  • High Estimate 1.69
  • Low Estimate 1.42
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +18.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.10 +0.63%
on 05/29/24
68.37 -7.12%
on 05/14/24
-2.44 (-3.70%)
since 04/29/24
3-Month
63.10 +0.63%
on 05/29/24
76.21 -16.68%
on 03/11/24
-8.60 (-11.93%)
since 02/29/24
52-Week
63.10 +0.63%
on 05/29/24
87.86 -27.73%
on 01/19/24
-13.59 (-17.63%)
since 05/26/23

Most Recent Stories

More News
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years

These companies have grown their dividends despite some troubles.

CVS : 53.67 (+0.07%)
GILD : 63.50 (-0.69%)
Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish?

Gilead Sciences has underperformed the broader market YTD, but Wall Street analysts are still cautiously optimistic about the stock’s prospects.

GILD : 63.50 (-0.69%)
$SPX : 5,266.95 (-0.74%)
XLV : 141.56 (-0.78%)
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript

GILD earnings call for the period ending March 31, 2024.

GILD : 63.50 (-0.69%)
Gilead: Q1 Earnings Snapshot

Gilead: Q1 Earnings Snapshot

GILD : 63.50 (-0.69%)
Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed...

ESM24 : 5,264.50 (-0.37%)
NQM24 : 18,716.75 (-0.46%)
META : 474.36 (-1.16%)
TSLA : 176.19 (-0.32%)
HAS : 60.23 (-2.46%)
TXN : 194.91 (-2.35%)
ODFL : 171.30 (-1.16%)
MSFT : 429.17 (-0.27%)
GOOGL : 175.90 (-0.28%)
MRK : 125.90 (-0.15%)
GILD : 63.50 (-0.69%)
CAT : 338.11 (-2.41%)
Better Growth Play: Merck or The Vanguard Growth Index Fund?

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

LLY : 811.53 (+0.45%)
PFE : 27.82 (-1.70%)
BMY : 40.25 (-0.59%)
NVO : 132.68 (-1.04%)
GILD : 63.50 (-0.69%)
MRK : 125.90 (-0.15%)
VUG : 356.12 (-0.36%)
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

Dividend stocks can be a smart way to ride out market volatility.

COMP : 3.79 (-4.77%)
NVDA : 1,148.25 (+0.81%)
WBA : 14.89 (-3.19%)
GILD : 63.50 (-0.69%)
KHC : 34.66 (-1.11%)
Biotech Breakthroughs Spearhead Fight Against Rising Breast Cancer Cases

USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases, which would represent a record high. Among 10 of the most common...

ONCY : 1.0900 (-0.91%)
ONC.TO : 1.49 (unch)
GILD : 63.50 (-0.69%)
GTHX : 3.34 (-1.76%)
AZN : 76.08 (-0.70%)
HOLX : 72.39 (-1.32%)
Biotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

ONCY : 1.0900 (-0.91%)
ONC.TO : 1.49 (unch)
GILD : 63.50 (-0.69%)
GTHX : 3.34 (-1.76%)
AZN : 76.08 (-0.70%)
HOLX : 72.39 (-1.32%)
3 No-Brainer Dividend Stocks to Buy in April

Income investors will find a lot to like about these stocks.

ABBV : 154.79 (-0.35%)
GILD : 63.50 (-0.69%)
PFE : 27.82 (-1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 64.72
2nd Resistance Point 64.31
1st Resistance Point 63.91
Last Price 63.50
1st Support Level 63.10
2nd Support Level 62.69
3rd Support Level 62.29

See More

52-Week High 87.86
Fibonacci 61.8% 78.40
Fibonacci 50% 75.48
Fibonacci 38.2% 72.56
Last Price 63.50
52-Week Low 63.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar